These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7680102)

  • 41. A comparison of the effects of aflatoxin B1 on the livers of rats and duck hepatitis B virus-infected and noninfected ducks.
    Seawright AA; Snowden RT; Olubuyide IO; Riley J; Judah DJ; Neal GE
    Hepatology; 1993 Jul; 18(1):188-97. PubMed ID: 8325610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolism and cytotoxicity of aflatoxin B1 in cultured rat hepatocytes and nonparenchymal cells: implications for tumorigenesis.
    Jennings GS; Heck R; Oesch F; Steinberg P
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):86-94. PubMed ID: 7974499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative inter-relationships between aflatoxin B1 carcinogen dose, indole-3-carbinol anti-carcinogen dose, target organ DNA adduction and final tumor response.
    Dashwood RH; Arbogast DN; Fong AT; Pereira C; Hendricks JD; Bailey GS
    Carcinogenesis; 1989 Jan; 10(1):175-81. PubMed ID: 2491968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Temporal patterns of DNA adduct formation and glutathione S-transferase activity in the testes of rats fed aflatoxin B1: a comparison with patterns in the liver.
    Sotomayor RE; Sahu S; Washington M; Hinton DM; Chou M
    Environ Mol Mutagen; 1999; 33(4):293-302. PubMed ID: 10398377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical detection of aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and nontumorous liver tissue.
    Santella RM; Zhang YJ; Chen CJ; Hsieh LL; Lee CS; Haghighi B; Yang GY; Wang LW; Feitelson M
    Environ Health Perspect; 1993 Mar; 99():199-202. PubMed ID: 8391434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does aflatoxin exposure in the United Kingdom constitute a cancer risk?
    Harrison JC; Carvajal M; Garner RC
    Environ Health Perspect; 1993 Mar; 99():99-105. PubMed ID: 8319666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alleviation of Aflatoxin B1-Induced Genomic Damage by Proanthocyanidins via Modulation of DNA Repair.
    Bakheet SA; Alhuraishi AM; Al-Harbi NO; Al-Hosaini KA; Al-Sharary SD; Attia MM; Alhoshani AR; Al-Shabanah OA; Al-Harbi MM; Imam F; Ahmad SF; Attia SM
    J Biochem Mol Toxicol; 2016 Nov; 30(11):559-566. PubMed ID: 27301782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole.
    Yates MS; Kwak MK; Egner PA; Groopman JD; Bodreddigari S; Sutter TR; Baumgartner KJ; Roebuck BD; Liby KT; Yore MM; Honda T; Gribble GW; Sporn MB; Kensler TW
    Cancer Res; 2006 Feb; 66(4):2488-94. PubMed ID: 16489057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative comparison between in vivo DNA adduct formation from exposure to selected DNA-reactive carcinogens, natural background levels of DNA adduct formation and tumour incidence in rodent bioassays.
    Paini A; Scholz G; Marin-Kuan M; Schilter B; O'Brien J; van Bladeren PJ; Rietjens IM
    Mutagenesis; 2011 Sep; 26(5):605-18. PubMed ID: 21642616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular dosimetry of urinary aflatoxin-N7-guanine and serum aflatoxin-albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats.
    Groopman JD; DeMatos P; Egner PA; Love-Hunt A; Kensler TW
    Carcinogenesis; 1992 Jan; 13(1):101-6. PubMed ID: 1733561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The association between aflatoxin exposure and primary hepatocellular carcinoma risks: a case-control study in Chongqing].
    Zheng CF; Zeng H; Wang J; Lin H; Feng XB; Chen JA; Qiu ZQ; Luo JH; Xu AW; Wang LQ; Tan Y; Chen S; Jiang P; Shu WQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):539-545. PubMed ID: 28592100
    [No Abstract]   [Full Text] [Related]  

  • 52. Aflatoxin-albumin adduct formation after single and multiple doses of aflatoxin B(1) in rats treated with Thai medicinal plants.
    Vinitketkumnuen U; Chewonarin T; Dhumtanom P; Lertprasertsuk N; Wild CP
    Mutat Res; 1999 Jul; 428(1-2):345-51. PubMed ID: 10518006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protection against aflatoxin B1 in rat--a new look at the link between toxicity, carcinogenicity, and metabolism.
    Ellis EM
    Toxicol Sci; 2009 May; 109(1):1-3. PubMed ID: 19293422
    [No Abstract]   [Full Text] [Related]  

  • 54. Bioactivation of aflatoxin B1 in the bovine olfactory mucosa: DNA binding, mutagenicity and induction of sister chromatid exchanges.
    Tjälve H; Larsson P; Andersson C; Busk L
    Carcinogenesis; 1992 Aug; 13(8):1345-50. PubMed ID: 1499086
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines.
    Macé K; Aguilar F; Wang JS; Vautravers P; Gómez-Lechón M; Gonzalez FJ; Groopman J; Harris CC; Pfeifer AM
    Carcinogenesis; 1997 Jul; 18(7):1291-7. PubMed ID: 9230270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Egg Yolk Immunoglobulin Supplementation Prevents Rat Liver from Aflatoxin B
    Qiu T; Shen X; Li X; Gong Y; Zou Z; Liu C; Ye F; Mi C; Xu Z; Sun Y; Lin J; Zhang H; Lei H
    J Agric Food Chem; 2018 Dec; 66(50):13260-13267. PubMed ID: 30449111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma.
    Long XD; Zhao D; Wang C; Huang XY; Yao JG; Ma Y; Wei ZH; Liu M; Zeng LX; Mo XQ; Zhang JJ; Xue F; Zhai B; Xia Q
    Epidemiology; 2013 Sep; 24(5):671-81. PubMed ID: 23788213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo formation of aflatoxin B1-DNA adducts in parenchymal and non-parenchymal cells of rat liver.
    Jennings GS; Oesch F; Steinberg P
    Carcinogenesis; 1992 May; 13(5):831-5. PubMed ID: 1586995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A high pressure liquid chromatography study on the removal of DNA-bound aflatoxin B1 in rat liver and in vitro.
    Hertzog PJ; Lindsay Smith JR; Garner RC
    Carcinogenesis; 1980 Sep; 1(9):787-93. PubMed ID: 11219870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer.
    Kensler TW; Gange SJ; Egner PA; Dolan PM; Muñoz A; Groopman JD; Rogers AE; Roebuck BD
    Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):603-10. PubMed ID: 9264273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.